Skip to main navigation
Enliven Therapeutics Logo
  • Home
  • About Us
    • Team
    • Board of Directors
    • Scientific Advisors
  • Approach
  • Pipeline
    • BCR-ABL Program
    • HER2 Program
    • Additional Programs
    • Program Presentations & Publications
    • Other Scientific Resources
  • Investors
    • News
      • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Corporate Governance
      • Governance Documents
      • Management
      • Board of Directors
      • Scientific Advisors
    • Financials & Filings
      • SEC Filings
    • IR Resources
      • FAQs
      • Email Alerts
      • Contact Us
  • Careers
    • Values
    • Job Opportunities
    • Recruiting Scam Notice
  • Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
January 13, 2026
Document Date
January 09, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
PATEL ANISH

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Print Page

Email Alerts

RSS Feeds

Contact Us

Investor Relations

  • News
    • Press Releases
  • Events & Presentations
    • Presentations
    • Upcoming Events
    • Past Events
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate Governance
    • Governance Documents
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact Us
  • More
    • Home
    • About Us
      • Team
      • Board of Directors
      • Scientific Advisors
    • Approach
    • Pipeline
      • BCR-ABL Program
      • HER2 Program
      • Additional Programs
      • Program Presentations & Publications
      • Other Scientific Resources
    • Investors
      • News
        • Press Releases
      • Events & Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historic Price Lookup
        • Analyst Coverage
      • Corporate Governance
        • Governance Documents
        • Management
        • Board of Directors
        • Scientific Advisors
      • Financials & Filings
        • SEC Filings
      • IR Resources
        • FAQs
        • Email Alerts
        • Contact Us
    • Careers
      • Values
      • Job Opportunities
      • Recruiting Scam Notice
    • Contact
    • Privacy Policy
    • Terms of Use
    Enliven Therapeutics Logo

    6200 Lookout Road
    Boulder, CO 80301

    General & Business Inquiries:
    info@enliventherapeutics.com

    Investor Inquiries:
    ir@enliventherapeutics.com

    Media Inquiries:
    media@enliventherapeutics.com

    Employment Inquiries:
    hr@enliventherapeutics.com

    LinkedIn

    • Privacy Policy
    • Terms of Use
    © 2026 Enliven Therapeutics All rights reserved.